Veracyte Financial Statements From 2010 to 2026

VCYT Stock  USD 38.08  0.66  1.70%   
Analyzing historical trends in various income statement and balance sheet accounts from Veracyte's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Veracyte's valuation are summarized below:
Gross Profit
349.6 M
Profit Margin
0.0612
Market Capitalization
B
Enterprise Value Revenue
5.5265
Revenue
495.1 M
There are currently one hundred twenty fundamental trend indicators for Veracyte that can be evaluated and compared over time across competition. All traders should double-check Veracyte's current fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 2.9 B in 2026. Enterprise Value is likely to gain to about 2.7 B in 2026

Veracyte Total Revenue

538.26 Million

Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.3 M, Interest Expense of 1.7 K or Selling General Administrative of 215.3 M, as well as many indicators such as Price To Sales Ratio of 13.72, Dividend Yield of 0.0 or PTB Ratio of 2.81. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
  
Build AI portfolio with Veracyte Stock
Check out the analysis of Veracyte Correlation against competitors.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Veracyte Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.6 B1.5 B536.3 M
Slightly volatile
Other Current Liabilities73.4 M69.9 M24.9 M
Slightly volatile
Total Current Liabilities94.9 M90.4 M34.3 M
Slightly volatile
Total Stockholder Equity1.4 B1.4 B480.7 M
Slightly volatile
Other Liabilities5.6 M8.7 M5.3 M
Slightly volatile
Property Plant And Equipment Net85.9 M81.8 M24.7 M
Slightly volatile
Accounts Payable6.3 M9.9 M5.7 M
Slightly volatile
Cash288.7 M275 M129.5 M
Slightly volatile
Non Current Assets Total1.1 B1.1 B358.8 M
Slightly volatile
Cash And Short Term Investments349.5 M332.9 M141.1 M
Slightly volatile
Net Receivables56.2 M53.5 M21.4 M
Slightly volatile
Common Stock Total Equity86.9 K82.8 K44 K
Slightly volatile
Common Stock Shares Outstanding94.4 M89.9 M45.2 M
Slightly volatile
Liabilities And Stockholders Equity1.6 B1.5 B536.3 M
Slightly volatile
Non Current Liabilities Total54.9 M52.3 M21.2 M
Slightly volatile
Inventory26.3 M25 M8.8 M
Slightly volatile
Other Current Assets17.6 M16.7 M6.2 M
Slightly volatile
Other Stockholder EquityB1.9 B740.1 M
Slightly volatile
Total Liabilities149.8 M142.7 M55.5 M
Slightly volatile
Property Plant And Equipment Gross133.5 M127.1 M33.9 M
Slightly volatile
Total Current Assets449.5 M428.1 M177.4 M
Slightly volatile
Common Stock46 K89.7 K42.5 K
Slightly volatile
Property Plant Equipment37.3 M35.5 M15.8 M
Slightly volatile
Intangible Assets64.7 M117.6 M55.7 M
Slightly volatile
Short and Long Term Debt Total61.3 M58.3 M20.8 M
Slightly volatile
Net Tangible Assets458 M436.2 M187.3 M
Slightly volatile
Long Term Debt884.9 K931.5 K6.5 M
Slightly volatile
Long Term Debt Total884.9 K931.5 K6.5 M
Slightly volatile
Capital Surpluse1.8 B1.7 B730.7 M
Slightly volatile
Deferred Long Term Liabilities4.3 M5.2 M4.1 M
Slightly volatile
Short and Long Term Debt963.6 KM5.3 M
Slightly volatile
Short Term Debt6.3 M6.8 MM
Very volatile
Current Deferred Revenue2.2 M1.9 M1.3 M
Slightly volatile
Net Invested Capital1.4 B1.4 B431.4 M
Slightly volatile
Net Working Capital211.5 M337.7 M140 M
Slightly volatile
Capital Stock69.6 K89.7 K54.7 K
Slightly volatile
Non Current Liabilities Other831.1 K874.8 K12.9 M
Slightly volatile

Veracyte Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization28.3 M27 M10.9 M
Slightly volatile
Selling General Administrative215.3 M205 M67.2 M
Slightly volatile
Selling And Marketing Expenses40.1 M31.9 M34.5 M
Slightly volatile
Total Revenue538.3 M512.6 M174.5 M
Slightly volatile
Other Operating Expenses518.8 M494.1 M199.1 M
Slightly volatile
Research Development83.7 M79.7 M28.6 M
Slightly volatile
Cost Of Revenue178.2 M169.8 M59.6 M
Slightly volatile
Total Operating Expenses340.5 M324.3 M139.5 M
Slightly volatile
Interest Income13.5 M12.8 M3.4 M
Slightly volatile
Reconciled Depreciation16 M27 M10.9 M
Slightly volatile

Veracyte Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation43.8 M41.7 M15.2 M
Slightly volatile
Begin Period Cash Flow262.4 M249.9 M112.5 M
Slightly volatile
Depreciation28.3 M27 M10.7 M
Slightly volatile
Capital Expenditures13.6 M13 M5.1 M
Slightly volatile
End Period Cash Flow290.6 M276.7 M130 M
Slightly volatile
Change To Netincome33.3 M31.8 M13.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.727.8115.7163
Slightly volatile
PTB Ratio2.812.967.8667
Slightly volatile
Days Sales Outstanding34.734.2941.6442
Slightly volatile
Book Value Per Share14.5313.847.4543
Slightly volatile
Stock Based Compensation To Revenue0.110.09350.1093
Slightly volatile
Capex To Depreciation1.010.550.8787
Slightly volatile
PB Ratio2.812.967.8667
Slightly volatile
Inventory Turnover7.627.817.2275
Pretty Stable
Days Of Inventory On Hand61.4861.8555.3328
Pretty Stable
Payables Turnover16.1615.399.1404
Slightly volatile
Sales General And Administrative To Revenue0.570.460.6078
Slightly volatile
Research And Ddevelopement To Revenue0.170.180.4875
Slightly volatile
Capex To Revenue0.05740.02910.0542
Slightly volatile
Cash Per Share3.844.353.3848
Very volatile
Days Payables Outstanding23.3224.5559.2891
Slightly volatile
Intangibles To Total Assets0.620.590.3191
Slightly volatile
Current Ratio4.94.265.8485
Pretty Stable
Tangible Book Value Per Share2.563.863.0451
Pretty Stable
Receivables Turnover11.0811.0210.2741
Slightly volatile
Graham Number8.369.410.2642
Slightly volatile
Shareholders Equity Per Share14.5313.847.4543
Slightly volatile
Debt To Equity0.04710.04960.1327
Pretty Stable
Capex Per Share0.130.170.114
Pretty Stable
Graham Net Net1.982.482.3257
Very volatile
Revenue Per Share5.515.252.9848
Slightly volatile
Interest Debt Per Share0.560.760.6583
Slightly volatile
Debt To Assets0.04260.04490.0832
Pretty Stable
Operating Cycle79.4282.6995.1999
Pretty Stable
Price Book Value Ratio2.812.967.8667
Slightly volatile
Days Of Payables Outstanding23.3224.5559.2891
Slightly volatile
Ebt Per Ebit0.831.441.0443
Pretty Stable
Company Equity Multiplier1.681.271.5074
Slightly volatile
Long Term Debt To Capitalization0.00210.00220.0858
Slightly volatile
Total Debt To Capitalization0.04520.04760.1011
Slightly volatile
Debt Equity Ratio0.04710.04960.1327
Pretty Stable
Quick Ratio4.874.015.7977
Pretty Stable
Net Income Per E B T0.770.840.9193
Slightly volatile
Cash Ratio4.032.744.781
Very volatile
Days Of Inventory Outstanding61.4861.8555.3328
Pretty Stable
Days Of Sales Outstanding34.734.2941.6442
Slightly volatile
Price To Book Ratio2.812.967.8667
Slightly volatile
Fixed Asset Turnover5.695.646.6109
Slightly volatile
Debt Ratio0.04260.04490.0832
Pretty Stable
Price Sales Ratio13.727.8115.7163
Slightly volatile
Asset Turnover0.510.390.4507
Pretty Stable
Price Fair Value2.812.967.8667
Slightly volatile

Veracyte Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.9 B2.7 B1.2 B
Slightly volatile
Enterprise Value2.7 B2.6 B1.1 B
Slightly volatile

Veracyte Fundamental Market Drivers

Forward Price Earnings27.027
Cash And Short Term Investments289.4 M

Veracyte Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.9 M2.2 M
Total Revenue512.6 M538.3 M
Cost Of Revenue169.8 M178.2 M
Stock Based Compensation To Revenue 0.09  0.11 
Sales General And Administrative To Revenue 0.46  0.57 
Research And Ddevelopement To Revenue 0.18  0.17 
Capex To Revenue 0.03  0.06 
Revenue Per Share 5.25  5.51 
Ebit Per Revenue 0.03  0.03 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.